SDRIFE: symmetric intertriginous flexural exanthema related to ciprofloxacin and/or nitrofurantoin administration: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20252185Keywords:
Symmetrical drug-related intertriginous and flexural exanthema, Ciprofloxacin, Nitrofurantoin, Drug eruption, Baboon syndrome, Perivascular lymphocytic infiltrate, HypersensibilityAbstract
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) is a self-limited cutaneous reaction induced by systemic drug exposure. It typically presents as sharply demarcated, symmetrical erythematous lesions affecting intertriginous areas such as the gluteal, perianal, and inguinal/perigenital regions, without systemic symptoms. Despite established diagnostic criteria, SDRIFE remains rarely reported, most often associated with antibiotics and less commonly with antifungals. We report the case of a 76-year-old woman with type 2 diabetes who developed SDRIFE after receiving ciprofloxacin and nitrofurantoin for a urinary tract infection. Treatment with corticosteroids led to marked clinical improvement. This case is of particular interest, as only one previous report has linked SDRIFE to ciprofloxacin, and none to nitrofurantoin. SDRIFE is believed to represent a type IV hypersensitivity reaction, most commonly triggered by beta-lactam antibiotics, though non-beta-lactams may also play a role. The clear temporal association between drug administration and symptom onset in our patient suggests a likely causal relationship. Given the limited documentation of SDRIFE associated with these agents, this case highlights the need to consider a broader range of potential drug triggers in patients presenting with this distinctive eruption.
Metrics
References
Schuler AM, Smith EH, Chaudet KM, Bresler SC, Gudjonsson JE, Kroshinsky D, et al. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature. J Cutan Pathol. 2021;48(12):1471-9. DOI: https://doi.org/10.1111/cup.14090
Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome. Contact Dermatitis. 2004;51(6):297-310. DOI: https://doi.org/10.1111/j.0105-1873.2004.00445.x
Arias Rodríguez C, Vélez Peláez MC, Gómez Gómez LV. Exantema intertriginoso y flexural simétrico relacionado con fármacos o síndrome del babuino. Dermatología Cosmética, Médica y Quirúrgica. 2023;21(3):155–9.
Megna M, Camela E, Ocampo Garza SS, Marino V, Costanzo L, Scalvenzi M, et al. Ciprofloxacin-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient. Contact Dermatitis. 2021;85(4):467-9. DOI: https://doi.org/10.1111/cod.13882
Harbaoui S, Litaiem N. Symmetrical Drug-Related Intertriginous and Flexural Exanthema. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.
Risi-Pugliese T, Barailler H, Hamelin A, Amsler E, Gaouar H, Kurihara F, et al. Milpied-Homsi B, Soria A. Symmetrical drug-related intertriginous and flexural exanthema: A little-known drug allergy. J Allergy Clin Immunol Pract. 2020;8(9):3185-9. DOI: https://doi.org/10.1016/j.jaip.2020.04.052
Nespoulous L, Matei I, Charissoux A, Bédane C, Assikar S. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature. Contact Dermatitis. 2018;79(6):378-80. DOI: https://doi.org/10.1111/cod.13084
Hausermann P, Bircher AJ. SDRIFE another acronym for a distinct cutaneous drug exanthema: do we really need it. Dermatology. 2007;214(1):1-2. DOI: https://doi.org/10.1159/000096903
Handisurya A, Stingl G, Wöhrl S. SDRIFE (baboon syndrome) induced by penicillin. Clin Exp Dermatol. 2009;34(3):355-7. DOI: https://doi.org/10.1111/j.1365-2230.2008.02911.x
Ferreira O, Mota A, Morais P, Cunha AP, Azevedo F. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide. Cutan Ocul Toxicol. 2010;29(4):293-5. DOI: https://doi.org/10.3109/15569527.2010.491103